DUBAI, UAE / ACCESSWIRE / June 19, 2015 / Trimax Corporation (www.trimaxcorporate.com) (PINKSHEETS: TMXN) is pleased to announce the appointment of Mr.Sender Vaiser as its Key Staff Executive Director in charge of Merchandising and Marketing . Sender Vaisers primary role will be in assisting the company to launch its time share yacht business model. Mr Vaiser brings with him more than 30 years in merchandising and franchising experience. He has been pivotal in launching many brands from coffee distribution systems, to vending machines, to various household products over his 30 plus years in the merchandising field.

Mr. Vaiser stated, “I’m pleased to be part of the Trimax team. This is a dynamic company with a couple of operating subsidiaries. We have some exciting events take place at Trimax which will all be announced in a timely manner including some very aggressive pricing on our product lines. We have a service provider in the yacht and real estate sector that is providing us some very liberal movements that should by all accounts make our product that much easier to market.”

CEO of Trimax Michael Arnkvarn concluded, “We are indeed very pleased to have Mr Sender Vaiser aboard TMXN. Mr Vaiser will be operating from our Dubai office. In addition to working on Merchandising and Marketing of our yacht time share product lines he will also be soliciting high net worth individuals for the purchase of our Trimax Yachts (www.trimaxyachts.com) and yacht dealerships and or marinas. TMXN has been relatively quiet for the past 3 years during our development stage. Now we are ready to roll Trimax out in full force as all of our affairs continue to line up in a better than expected formation.”

In other company news and events: The management is of the opinion that the following is a significant event that warrants mentioning in a public news release. Some of our followers have been inquiring about a certain listing on a certain Merger Network web site, where amongst other things Trimax control block was being advertised for sale. The management confirms that this listing was active during Trimax rebuilding stage (2012-2015) or change of business direction from a mining exploration company to a holding company engaged in timeshare of yachts and real estate, import and export business and agro commerce. See TMXN web site encompassing all corporate activities. (www.trimaxcorporate.com) During this quiet or rebuilding period, Trimax management was exploring all of its options and all avenues to maximize shareholder values. Recently this advertisement has been removed as it served its purpose. The aforementioned objectives were either met or far exceeded management’s expectations. Details of this exercise will be released under a separate news release. The management is of the opinion that the results as they begin to crystalize and come to fruition should by all accounts reflect positively on the entire Trimax organization, and its valuation.

More news and further developments will be released shortly and on a timely basis.

CONTACT:

corporate@trimaxcorporate.com

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of TMXN that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases “can be,” “expects,” “may affect,” “believed,” “estimate,” “project,” and similar words and phrases are intended to identify such forward-looking statements. TMXN. cautions you that any forward-looking information provided by or on behalf of TMXN. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. TMXN actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond TMXN control. In addition to those discussed in TMXN press releases, public filings, and statements by TMXN management, but not limited to, TMXN estimate of the sufficiency of its existing capital resources, TMXN ability to raise additional capital to fund future operations, TMXN ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match TMXN capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. TMXN does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

SOURCE: Trimax Corporation

ReleaseID: 429980

CORONA, CA / ACCESSWIRE / June 19, 2015 / Definitive Rest Mattress Company (PINKSHEETS: DRMC) The company’s new direction is in gear and performing as expected. New products, increased sales with solid contracts and strong customer base.

Having officially disbanded all previous operations, DRMC and its new executive management team are on pace to meet its revenue projections for the 3rd quarter of 2015, our new customer base and new product line has opened the doors to many exciting opportunities in the sectors of Aerospace, Defense and Commercial component manufacturers, Domestic and International.

“Recent orders from Asia and domestic companies for Stainless and Aluminum, have set the tone for NU Metals Technology, by securing orders until the end of 2015, our future is solid moving forward with new business partners, new company direction and a new mind set, our shareholders will be happy to see DRMC sales activity on the next quarterly report,” says Juan Carlos Murga, CEO President of DRMC.

The Company is also in the process of completing its new web site, with a new personality to showcase a complete and diverse line of products for the a global customer base, including Tooling and CNC Machinery solutions.

About Definitive Rest Mattress Company:

Definitive Rest Mattress Company is an Oklahoma corporation with it’s headquarter office located in Corona, California. The Company previously engaged in the manufacturing and sales of mattresses. In 2015, the Company has embarked upon a change of business direction into the Aerospace and Industrial Metals Sector. Please visit http://www.numetalstech.com/.

Safe Harbor:

Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company’s future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company’s affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company’s filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact:

Nu Metals Technology
Email: sales@numetalstech.com

SOURCE: Definitive Rest Mattress Company

ReleaseID: 429974

VANCOUVER, BC / ACCESSWIRE / June 19, 2015 / Naturally Splendid Enterprises Ltd. (the “Naturally Splendid” or “NSE”) (FRANKFURT: 50N.F) (TSX VENTURE: NSP) (OTCQB: NSPDF) is pleased to announce it has completed its acquisition of 51 Class A shares of POS BPC Manufacturing Corp. (“BPC“), being 51% of the issued shares of BPC, in accordance with the terms of a securities purchase agreement (the “Purchase Agreement“) with POS Management Corp. (“POS Management“) and POS Holdings Corp. (“POS“). In consideration of the BPC shares, Naturally Splendid paid CAD $1,750,000 (the “Cash Payment“) to POS Management and issued 367,647 common shares of Naturally Splendid (the “Consideration Shares“) to POS Management at a deemed price of $0.68 per share. The Consideration Shares will be subject to a restriction of trading for a period of 12 months from the date of issue.

Naturally Splendid Co-Founder Bryan Carson reports, “This strategic acquisition of the POS BPC facility positions Naturally Splendid to compete in the rapid and aggressively growing food, beverage, cosmetic and pet care ingredients industry.” Through this acquisition, NSE has the ability to seamlessly coordinate the entire plant-to-product process by utilizing the expertise of POS’ R&D scientists; from sourcing bioactive, plant-based ingredients, to overseeing toll processing, to formulation, and to creating unique custom ingredient solutions, NSE has the unique opportunity of offering their clients the convenience of comprehensive solutions and services.

BPC operates the 12,000 square foot facility (the “BPC Facility“) containing approximately 60,000L of tankage, a fractional distillation system, evaporation equipment, spray drying equipment, a ring dryer and various other pieces of complementary & auxiliary equipment owned by BPC. It is capable of processing a variety of products including the suite of plant-based omega technologies such as HempOmega(R) (www.hempomega.com) that Naturally Splendid has licensed from Full Spectrum Laboratories. Additionally, the BPC Facility is designed to produce plant-based extracts, tinctures and dry ingredients for a variety of clients.

Further, Naturally Splendid, POS and BPC entered into a unanimous shareholders agreement that provides, among other things, equal board representation for each of Naturally Splendid, which will hold 51 Class A shares of BPC, and POS, which will hold 49 Class A Shares of BPC. Dale Kelly, being the President of POS, will serve as Chief Executive Officer of BPC. David Racz, being a director of Naturally Splendid, will be put forward by Naturally Splendid as the initial Chairman of the board of directors, which will require official confirmation by the new Board of Directors of BPC at the first meeting of the Board to be held after the closing of the transaction.

Also, Naturally Splendid entered into a license agreement with POS Bio-Sciences, whereby Naturally Splendid has the right to sell and market, on an exclusive basis, five (5) ingredients created using POS Bio-Sciences’ technology (the “Exclusive Products“) and sell and market, on a non-exclusive basis, additional ingredients created using POS technologies (the “Non-Exclusive Products“). In consideration of the license, Naturally Splendid has agreed to pay POS a 5% net revenue royalty. The ingredients included in this licensing arrangement are of high quality sourced plant and marine extracts in the form of powder or oil and will be marketed through Naturally Splendid’s recently launched BC Ingredients (BCI) division (www.bcingredients.com).

BCI’s line-up of globally sourced, plant-based ingredients currently includes ginseng, fenugreek, moringa, baobab, broccoli extract and HempOmega(R), the company’s flagship. The nutritional profiles of the ingredients boast high mineral, vitamin, anti-oxidant, protein, and omega fatty acid content, that help to maintain a balanced diet and optimum health. Market and Markets report the bio-active ingredients market is projected to reach $33 billion by the year 2018. The demand for products with sustainable, natural, nutritional and effective ingredients is rapidly growing, and BCI’s offerings have the ability to satisfy this demand. Whether manufacturers are looking to develop value-added foods, cosmetics, beverages, pet care products, pet foods, livestock feed or other innovative products, BCI has access to the highest quality ingredients, facilities and services.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a multifaceted biotechnology company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient-dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications. Naturally Splendid currently has four innovative divisions: (1) Natera(TM) brand of retail hemp superfood products currently distributed throughout North America; (2) PawsitiveFX(TM) brand of pet care products; (3) BCI(TM) division of plant-derived bulk ingredients including patent-pending HempOmega(TM); and (4) hemp-based cannabinoid pharmaceuticals and nutraceuticals. The Company’s advanced technologies, industry expertise, and strategic partners allow for the creation of customized solutions with a consistent focus on quality and sustainability.

www.naturallysplendid.com

About POS Bio-Sciences (www.pos.ca)

POS Bio-Sciences specializes in the creation of value added products from biological materials, for uses in food supplements, nutraceuticals, cosmetics, biofuels, and medical devices. POS Bio-Sciences provides research and development services to hundreds of companies from around the world who are looking to develop and commercialize processes for extracting, fractionating, modifying, and/or purifying valuable components of biological materials. The facilities used by POS Bio-Sciences allow for on-site analytical testing as well as trials at lab scale, mini-pilot plant scale, and pilot scale. POS Bio-Sciences also provides custom and toll processing services to companies that require a back-up manufacturer, an interim manufacturer while in the process of building their own production facilities, and companies that do not wish to invest in their own production facilities.

All POS Bio-Sciences processes are GMP-compliant and fully supported by quality assurance, commitment to regulatory compliance, and certification to international standards. POS Bio-Sciences also offers a suite of support services to assist clients and ensure that project outcomes meet their needs and expectations.

POS Bio-Sciences is a registered business name of POS Management Corp.

For more information e-mail info@naturallysplendid.com or call 604-673-9573

On Behalf of the Board of Directors

J. Craig Goodwin
CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N.F – Frankfurt)
2435 Beta Avenue
Burnaby, BC, V5C 5N1
Phone: (604) 570-0902
Fax: (604) 570-0934
E-mail: info@naturallysplendid.com
Website: www.naturallysplendid.com

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control. There is no guarantee that Naturally Splendid’s plans will be found to be commercially viable; Naturally Splendid’s ability to compete with large food and beverage companies; sales of any products developed will be profitable; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE: Naturally Splendid Enterprises Ltd. 

ReleaseID: 429982

VANCOUVER, BC / ACCESSWIRE / June 19, 2015 / Williams Creek Gold Limited (TSXV: WCX) (the “Company”) announces that, effective immediately, Dr. Hans Black, has resigned as Chairman and Director of the Company.

This follows a June 17th, 2015 news release from the US Securities Exchange Commission, announcing fraud charges against a Massachusetts based investment advisory firm (Interinvest Corporation) and its owner (Dr. Hans Peter Black). Williams Creek Gold is not a party to this action.

On behalf of the board of directors

Stephen Leahy
CEO

For additional information please visit www.williamscreek.ca or contact Stephen Leahy, CEO at 604-729-4573

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Williams Creek Gold Limited 

ReleaseID: 429981

ReleaseID: 429975

HORSHAM, PA / ACCESSWIRE / June 19, 2015 / Whether it’s a Father’s Day gift or simply a gift to yourself as a car owner, a summer tune-up is a good way to keep your car running smoothly and safely. The annual salute to Dads is good time to think about summer car care, since this is when most of us spend more time in our cars, vacationing or taking weekend or day trips.

“A few simple steps at the start of the summer can keep your car running smoothly, safely and efficiently,” says Paul Dintino, an ASE Master Technician and Director of National Accounts at Cottman Transmission and Total Auto Care, a brand with locations across the U.S. that services almost any make or model vehicle, foreign or domestic.

1. Check the tire pressure.

Dintino recommends checking the air pressure in all the tires. The recommended air pressure varies by make and model, so it’s important to refer to the owner’s manual. It’s important not to exceed the recommended pressure, especially in the summer when air temperatures and road surfaces are hotter, since air expands with heat. Maintaining the proper tire pressure helps provide a safe and smooth ride, and it also helps with fuel efficiency, since under-inflated tires add friction that works against the engine.

2. Be sure the air filter is clean.

It’s important to check the air filter to be sure it’s clean. A dirty filter prevents the proper amount of air to get into the system, and an improper mixture of fuel and air retards the efficiency of combustion in the engine, lowering the gas mileage.

3. Check wheel alignment.

The wheels should be checked at least once a year for proper alignment, Dintino says. “It’s especially important to check the wheel alignment after a rough winter since icy roads and potholes can knock the alignment off,” he adds. Improper wheel alignment can be costly, since it causes tires to wear unevenly and more quickly, and it also creates more drag which lowers gas mileage.

4. Check the coolant.

Coolant helps prevent the water in the radiator from boiling and evaporating, which can leave you stranded. Running the engine without proper coolant can also cause major engine damage. It’s especially important in the warm weather of summer, when air temperatures are higher and the car’s air conditioning is often in use.

Many of the new cars have what’s called “closed systems” which cannot be opened without proper equipment, so it’s best to have a service center check the water level and the amount of coolant. If you have an older model that enables you to open the radiator, only do so when the car is cold. Never open the radiator cap after the car has been running or serious injury could occur.

5. Check your brakes.

Don’t wait until you hear your brakes squeak, Dintino says. Brakes should be checked once a year, and the start of the summer driving season is a good time to have it done.

“Some advance care as the summer begins can help keep your car running smoothly and safely,” says Cottman Transmission and Total Auto Care’s Dintino. And that’s a great gift for any dad or car owner.

About Cottman Transmission and Total Auto Care:

With locations across the U.S., Cottman Transmission and Total Auto Care is a transmission and auto repair brand that services almost any make or model vehicle, foreign or domestic. Cottman Transmission and Total Auto Care centers specialize in complete transmission service, brakes, suspension, air conditioning service and much more. Cottman’s headquarters is based in Horsham, Pennsylvania. For more information, please visit www.Cottman.com and www.TheCottmanManBlog.com.

Contact:

Derik Beck
dbeck@cottman.com
267-464-7212

SOURCE: Cottman Transmission and Total Auto Care

ReleaseID: 429887

MELBOURNE, AUSTRALIA / ACCESSWIRE / June 19, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) (“Propanc” or “the Company”), an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced a summary of Corporate and R&D activities currently underway as part of a shareholder update since presenting at the SeeThru Equity Conference last month.

Since the conference, research undertaken by Propanc’s research partners at the Universities of Jaen and Granada has produced some initial exciting results. Management and their research partners believe the data generated could result in patentable subject matter. Consequently, information will be released once further testing and evaluation is conducted and a final determination made on patentability of the subject matter.

Pilot animal studies are ongoing for PRP and results will be reported at the earliest opportunity when the data set is complete and reports are evaluated. Studies in several tumor types implanted in mice remain on track. 

“We view these pilot studies as incremental, but important steps to understand the effects of PRP in numerous cancer cell types when administered by I.V injection,” said James Nathanielsz, Propanc’s Chief Executive Officer. “These studies are providing important information about the dosing and exposure of PRP, and hence, its potential safety profile prior to entering into animal toxicology studies, as well as human trials. We want to ensure that the data generated will assist with maximizing results when we enter the clinic.”

Additionally, the Company is seeking input from drug development experts and regulatory consultants as it considers the best time for meeting with healthcare regulatory agencies to obtain scientific advice for conducting the next stage of formal safety studies for PRP.

Propanc continues to field interest from potential investors willing to finance the Company’s R&D activities for PRP through the preclinical development stage in preparation for human trials. The management team is conscious this represents an opportunity to strengthen the Company’s financial position, but will consider terms carefully to ensure the long term future the Company and its shareholders.

In preparation for its proposed up-listing to a national exchange, the Company is working towards strengthening its Board of Advisors who could assist with execution of the Company’s strategic plan.

The Company also continues to carefully evaluate opportunities to fast track growth and strengthen the company’s portfolio. These opportunities will be carefully considered with the Company’s Advisors to determine their potential suitability. Nevertheless, management remains committed to identifying potential new projects, as part of its long term strategic objectives for growth.

About Propanc:

We are a development stage healthcare company that is currently focused on developing new cancer treatments for patients suffering from pancreatic and colorectal cancer. Together with our scientific and oncology consultants, we have developed a rational, composite formulation of anti-cancer compounds which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our leading products are variations upon our novel formulation and involve or employ proenzymes, which are inactive precursors of enzymes. As a result of positive early indications of the anti-cancer effects of our technology, we intend to submit our proenzyme treatment to the rigorous, formal non-clinical and clinical development and trial processes required to obtain the regulatory approval necessary to commercialize it and any product(s) derived and/or to be derived therefrom.

In the near term, we intend to target patients with limited remaining therapeutic options for the treatment of solid tumors such as colorectal or pancreatic tumors. In the future, we intend to development our lead product to treat (i) early stage cancer and (ii) pre-cancerous diseases and (iii) as a preventative measure for patients at risk of developing cancer based on genetic screening. For more information, please visit: www.propanc.com.

Forward-looking Statements:

Certain of the matters discussed in this announcement involve risks and uncertainties including, without limitation, those regarding the Company’s ability to establish and maintain the proprietary nature of its technology through the patent process, its ability to license from others patents and patent applications, if necessary, to develop certain products, its ability to implement its long range business plan for various applications of its technology, and its ability to enter into agreements with any necessary marketing and/or distribution partners for purposes of commercialization. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company’s financial position. See Propanc’s most recent Quarterly Report on Form 10-Q and related 8K filings. 

Contact:

Regal Consulting
Tel: 702 – 575 – 9157

SOURCE: Propanc Health Group Corporation

ReleaseID: 429979